Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 439

1.

Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score.

Onengut-Gumuscu S, Chen WM, Robertson CC, Bonnie JK, Farber E, Zhu Z, Oksenberg JR, Brant SR, Bridges SL Jr, Edberg JC, Kimberly RP, Gregersen PK, Rewers MJ, Steck AK, Black MH, Dabelea D, Pihoker C, Atkinson MA, Wagenknecht LE, Divers J, Bell RA; SEARCH for Diabetes in Youth; Type 1 Diabetes Genetics Consortium, Erlich HA, Concannon P, Rich SS.

Diabetes Care. 2019 Mar;42(3):406-415. doi: 10.2337/dc18-1727. Epub 2019 Jan 18.

PMID:
30659077
2.

Correction: High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis.

Mack SJ, Udell J, Cohen F, Osoegawa K, Hawbecker SK, Noonan DA, Ladner MB, Goodridge D, Trachtenberg EA, Oksenberg JR, Erlich HA.

Genes Immun. 2019 Apr;20(4):340. doi: 10.1038/s41435-018-0037-9.

PMID:
29915315
3.

Target capture enrichment of nuclear SNP markers for massively parallel sequencing of degraded and mixed samples.

Bose N, Carlberg K, Sensabaugh G, Erlich H, Calloway C.

Forensic Sci Int Genet. 2018 May;34:186-196. doi: 10.1016/j.fsigen.2018.01.010. Epub 2018 Feb 4.

PMID:
29524767
4.
5.

Applications of Probe Capture Enrichment Next Generation Sequencing for Whole Mitochondrial Genome and 426 Nuclear SNPs for Forensically Challenging Samples.

Shih SY, Bose N, Gonçalves ABR, Erlich HA, Calloway CD.

Genes (Basel). 2018 Jan 22;9(1). pii: E49. doi: 10.3390/genes9010049. Erratum in: Genes (Basel). 2018 Feb 14;9(2):.

6.

High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis.

Mack SJ, Udell J, Cohen F, Osoegawa K, Hawbecker SK, Noonan DA, Ladner MB, Goodridge D, Trachtenberg EA, Oksenberg JR, Erlich HA.

Genes Immun. 2019 Apr;20(4):308-326. doi: 10.1038/s41435-017-0006-8. Epub 2018 Jan 8. Erratum in: Genes Immun. 2018 Jun 18;:.

7.

Co-occurrence of Type 1 Diabetes and Celiac Disease Autoimmunity.

Hagopian W, Lee HS, Liu E, Rewers M, She JX, Ziegler AG, Lernmark Å, Toppari J, Rich SS, Krischer JP, Erlich H, Akolkar B, Agardh D; TEDDY Study Group.

Pediatrics. 2017 Nov;140(5). pii: e20171305. doi: 10.1542/peds.2017-1305. Epub 2017 Oct 10.

8.

A phylogenetic approach for haplotype analysis of sequence data from complex mitochondrial mixtures.

Vohr SH, Gordon R, Eizenga JM, Erlich HA, Calloway CD, Green RE.

Forensic Sci Int Genet. 2017 Sep;30:93-105. doi: 10.1016/j.fsigen.2017.05.007. Epub 2017 May 29.

9.

MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo.

Cavalli G, Hayashi M, Jin Y, Yorgov D, Santorico SA, Holcomb C, Rastrou M, Erlich H, Tengesdal IW, Dagna L, Neff CP, Palmer BE, Spritz RA, Dinarello CA.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1363-8. doi: 10.1073/pnas.1523482113. Epub 2016 Jan 19.

10.
11.

The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.

Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1304-10. doi: 10.1158/1055-9965.EPI-14-1353. Epub 2015 Jun 18.

12.

Very high resolution single pass HLA genotyping using amplicon sequencing on the 454 next generation DNA sequencers: Comparison with Sanger sequencing.

Yamamoto F, Höglund B, Fernandez-Vina M, Tyan D, Rastrou M, Williams T, Moonsamy P, Goodridge D, Anderson M, Erlich HA, Holcomb CL.

Hum Immunol. 2015 Dec;76(12):910-6. doi: 10.1016/j.humimm.2015.05.002. Epub 2015 May 30.

PMID:
26037172
13.

HLA-DPB1*04:01 Protects Genetically Susceptible Children from Celiac Disease Autoimmunity in the TEDDY Study.

Hadley D, Hagopian W, Liu E, She JX, Simell O, Akolkar B, Ziegler AG, Rewers M, Krischer JP, Chen WM, Onengut-Gumuscu S, Bugawan TL, Rich SS, Erlich H, Agardh D; TEDDY Study Group.

Am J Gastroenterol. 2015 Jun;110(6):915-20. doi: 10.1038/ajg.2015.150. Epub 2015 May 26.

14.

HLA typing using next generation sequencing: An overview.

Erlich HA.

Hum Immunol. 2015 Dec;76(12):887-90. doi: 10.1016/j.humimm.2015.03.001. Epub 2015 Mar 14. Review. No abstract available.

PMID:
25777625
15.

Major association of vitiligo with HLA-A*02:01 in Japanese.

Jin Y, Hayashi M, Fain PR, Suzuki T, Fukai K, Oiso N, Tanemura A, Holcomb CL, Rastrou M, Erlich HA, Spritz RA.

Pigment Cell Melanoma Res. 2015 May;28(3):360-2. doi: 10.1111/pcmr.12356. Epub 2015 Feb 17. No abstract available.

16.

A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.

Schiffman M, Burk RD, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Aldrich C, Tam T, Erlich H, Apple R, Befano B, Castle PE.

J Clin Microbiol. 2015 Jan;53(1):52-9. doi: 10.1128/JCM.02116-14. Epub 2014 Oct 22.

17.

Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function.

Lin L, Ma C, Wei B, Aziz N, Rajalingam R, Yusung S, Erlich HA, Trachtenberg EA, Targan SR, McGovern DP, Heath JR, Braun J.

J Immunol. 2014 Jul 15;193(2):940-9. doi: 10.4049/jimmunol.1400093. Epub 2014 Jun 16.

18.

Next-generation sequencing can reveal in vitro-generated PCR crossover products: some artifactual sequences correspond to HLA alleles in the IMGT/HLA database.

Holcomb CL, Rastrou M, Williams TC, Goodridge D, Lazaro AM, Tilanus M, Erlich HA.

Tissue Antigens. 2014 Jan;83(1):32-40. doi: 10.1111/tan.12269.

PMID:
24355006
19.

Association of Parkinson disease with structural and regulatory variants in the HLA region.

Wissemann WT, Hill-Burns EM, Zabetian CP, Factor SA, Patsopoulos N, Hoglund B, Holcomb C, Donahue RJ, Thomson G, Erlich H, Payami H.

Am J Hum Genet. 2013 Nov 7;93(5):984-93. doi: 10.1016/j.ajhg.2013.10.009. Epub 2013 Oct 31.

20.

Receiver operating characteristic analysis of HLA, CTLA4, and insulin genotypes for type 1 diabetes.

Valdes AM, Varney MD, Erlich HA, Noble JA.

Diabetes Care. 2013 Sep;36(9):2504-7. doi: 10.2337/dc12-2284. Epub 2013 Apr 29.

21.

Prediction of type 1 diabetes.

Erlich HA, Valdes AM, Noble JA.

Diabetes. 2013 Apr;62(4):1020-1. doi: 10.2337/db12-1593. No abstract available.

22.

Next generation sequencing reveals the association of DRB3*02:02 with type 1 diabetes.

Erlich HA, Valdes AM, McDevitt SL, Simen BB, Blake LA, McGowan KR, Todd JA, Rich SS, Noble JA; Type 1 Diabetes Genetics Consortium (T1DGC).

Diabetes. 2013 Jul;62(7):2618-22. doi: 10.2337/db12-1387. Epub 2013 Mar 5.

23.

Development and characterization of the cobas human papillomavirus test.

Rao A, Young S, Erlich H, Boyle S, Krevolin M, Sun R, Apple R, Behrens C.

J Clin Microbiol. 2013 May;51(5):1478-84. doi: 10.1128/JCM.03386-12. Epub 2013 Feb 27.

24.

High throughput HLA genotyping using 454 sequencing and the Fluidigm Access Array™ System for simplified amplicon library preparation.

Moonsamy PV, Williams T, Bonella P, Holcomb CL, Höglund BN, Hillman G, Goodridge D, Turenchalk GS, Blake LA, Daigle DA, Simen BB, Hamilton A, May AP, Erlich HA.

Tissue Antigens. 2013 Mar;81(3):141-9. doi: 10.1111/tan.12071.

PMID:
23398507
25.

16(th) IHIW : review of HLA typing by NGS.

De Santis D, Dinauer D, Duke J, Erlich HA, Holcomb CL, Lind C, Mackiewicz K, Monos D, Moudgil A, Norman P, Parham P, Sasson A, Allcock RJ.

Int J Immunogenet. 2013 Feb;40(1):72-6. doi: 10.1111/iji.12024.

26.

A sequence-based approach demonstrates that balancing selection in classical human leukocyte antigen (HLA) loci is asymmetric.

Bronson PG, Mack SJ, Erlich HA, Slatkin M.

Hum Mol Genet. 2013 Jan 15;22(2):252-61. doi: 10.1093/hmg/dds424. Epub 2012 Oct 12.

27.

Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY).

Frederiksen B, Liu E, Romanos J, Steck AK, Yin X, Kroehl M, Fingerlin TE, Erlich H, Eisenbarth GS, Rewers M, Norris JM.

J Steroid Biochem Mol Biol. 2013 Jan;133:51-7. doi: 10.1016/j.jsbmb.2012.08.012. Epub 2012 Sep 7.

28.

HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk.

Urayama KY, Chokkalingam AP, Metayer C, Ma X, Selvin S, Barcellos LF, Wiemels JL, Wiencke JK, Taylor M, Brennan P, Dahl GV, Moonsamy P, Erlich HA, Trachtenberg E, Buffler PA.

Blood. 2012 Oct 11;120(15):3039-47. doi: 10.1182/blood-2012-01-404723. Epub 2012 Aug 24.

29.

Evidence of gene-gene interaction and age-at-diagnosis effects in type 1 diabetes.

Howson JM, Cooper JD, Smyth DJ, Walker NM, Stevens H, She JX, Eisenbarth GS, Rewers M, Todd JA, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Pociot F, Rich SS; Type 1 Diabetes Genetics Consortium.

Diabetes. 2012 Nov;61(11):3012-7. doi: 10.2337/db11-1694. Epub 2012 Aug 13.

30.

Use of class I and class II HLA loci for predicting age at onset of type 1 diabetes in multiple populations.

Valdes AM, Erlich HA, Carlson J, Varney M, Moonsamy PV, Noble JA.

Diabetologia. 2012 Sep;55(9):2394-401. doi: 10.1007/s00125-012-2608-z. Epub 2012 Jun 17.

31.

HLA DNA typing: past, present, and future.

Erlich H.

Tissue Antigens. 2012 Jul;80(1):1-11. doi: 10.1111/j.1399-0039.2012.01881.x. Review.

PMID:
22651253
32.

Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation.

Jin Y, Ferrara T, Gowan K, Holcomb C, Rastrou M, Erlich HA, Fain PR, Spritz RA.

J Invest Dermatol. 2012 Jun;132(6):1730-3. doi: 10.1038/jid.2012.37. Epub 2012 Mar 8. No abstract available.

33.

Genetics of type 1 diabetes.

Noble JA, Erlich HA.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007732. doi: 10.1101/cshperspect.a007732. Review.

34.

Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma.

Skibola CF, Akers NK, Conde L, Ladner M, Hawbecker SK, Cohen F, Ribas F, Erlich HA, Goodridge D, Trachtenberg EA, Smith MT, Bracci PM.

Tissue Antigens. 2012 Apr;79(4):279-86. doi: 10.1111/j.1399-0039.2012.01845.x. Epub 2012 Feb 2.

35.

Confirmation of novel type 1 diabetes risk loci in families.

Cooper JD, Howson JM, Smyth D, Walker NM, Stevens H, Yang JH, She JX, Eisenbarth GS, Rewers M, Todd JA, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Pociot F, Rich SS; Type 1 Diabetes Genetics Consortium.

Diabetologia. 2012 Apr;55(4):996-1000. doi: 10.1007/s00125-012-2450-3. Epub 2012 Jan 26.

36.

No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY).

Simpson M, Brady H, Yin X, Seifert J, Barriga K, Hoffman M, Bugawan T, Barón AE, Sokol RJ, Eisenbarth G, Erlich H, Rewers M, Norris JM.

Diabetologia. 2011 Nov;54(11):2779-88. doi: 10.1007/s00125-011-2278-2. Epub 2011 Aug 20.

37.

Multiple loci in the HLA complex are associated with Addison's disease.

Skinningsrud B, Lie BA, Lavant E, Carlson JA, Erlich H, Akselsen HE, Gervin K, Wolff AB, Erichsen MM, Løvås K, Husebye ES, Undlien DE.

J Clin Endocrinol Metab. 2011 Oct;96(10):E1703-8. doi: 10.1210/jc.2011-0645. Epub 2011 Aug 3.

PMID:
21816777
38.

Pathway-based analysis of genetic susceptibility to cervical cancer in situ: HLA-DPB1 affects risk in Swedish women.

Ivansson EL, Juko-Pecirep I, Erlich HA, Gyllensten UB.

Genes Immun. 2011 Dec;12(8):605-14. doi: 10.1038/gene.2011.40. Epub 2011 Jun 30.

PMID:
21716314
39.

The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.

Hagopian WA, Erlich H, Lernmark A, Rewers M, Ziegler AG, Simell O, Akolkar B, Vogt R Jr, Blair A, Ilonen J, Krischer J, She J; TEDDY Study Group.

Pediatr Diabetes. 2011 Dec;12(8):733-43. doi: 10.1111/j.1399-5448.2011.00774.x. Epub 2011 May 12.

40.

A multi-site study using high-resolution HLA genotyping by next generation sequencing.

Holcomb CL, Höglund B, Anderson MW, Blake LA, Böhme I, Egholm M, Ferriola D, Gabriel C, Gelber SE, Goodridge D, Hawbecker S, Klein R, Ladner M, Lind C, Monos D, Pando MJ, Pröll J, Sayer DC, Schmitz-Agheguian G, Simen BB, Thiele B, Trachtenberg EA, Tyan DB, Wassmuth R, White S, Erlich HA.

Tissue Antigens. 2011 Mar;77(3):206-17. doi: 10.1111/j.1399-0039.2010.01606.x.

41.

Tests for genetic interactions in type 1 diabetes: linkage and stratification analyses of 4,422 affected sib-pairs.

Morahan G, Mehta M, James I, Chen WM, Akolkar B, Erlich HA, Hilner JE, Julier C, Nerup J, Nierras C, Pociot F, Todd JA, Rich SS; Type 1 Diabetes Genetics Consortium.

Diabetes. 2011 Mar;60(3):1030-40. doi: 10.2337/db10-1195. Epub 2011 Jan 24.

42.

Homozygosity for the Ala allele of the PPARγ2 Pro12Ala polymorphism is associated with reduced risk of coronary artery disease.

Galgani A, Valdes A, Erlich HA, Mano C, Cheng S, Petrone A, Sentinelli F, Berni A, Baroni MG, Buzzetti R.

Dis Markers. 2010;29(5):259-64. doi: 10.3233/DMA-2010-0756.

43.

Letter from jerusalem.

Erlich HS.

Int J Psychoanal. 2010 Dec;91(6):1329-35. doi: 10.1111/j.1745-8315.2010.00332.x. No abstract available.

PMID:
21133901
44.

Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY).

Stene LC, Oikarinen S, Hyöty H, Barriga KJ, Norris JM, Klingensmith G, Hutton JC, Erlich HA, Eisenbarth GS, Rewers M.

Diabetes. 2010 Dec;59(12):3174-80. doi: 10.2337/db10-0866. Epub 2010 Sep 21.

45.

HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.

Noble JA, Valdes AM, Varney MD, Carlson JA, Moonsamy P, Fear AL, Lane JA, Lavant E, Rappner R, Louey A, Concannon P, Mychaleckyj JC, Erlich HA; Type 1 Diabetes Genetics Consortium.

Diabetes. 2010 Nov;59(11):2972-9. doi: 10.2337/db10-0699. Epub 2010 Aug 26.

46.

HLA genotyping in the international Type 1 Diabetes Genetics Consortium.

Mychaleckyj JC, Noble JA, Moonsamy PV, Carlson JA, Varney MD, Post J, Helmberg W, Pierce JJ, Bonella P, Fear AL, Lavant E, Louey A, Boyle S, Lane JA, Sali P, Kim S, Rappner R, Williams DT, Perdue LH, Reboussin DM, Tait BD, Akolkar B, Hilner JE, Steffes MW, Erlich HA; T1DGC.

Clin Trials. 2010;7(1 Suppl):S75-87. doi: 10.1177/1740774510373494. Epub 2010 Jul 1.

47.

Genetics of type 1 diabetes: what's next?

Pociot F, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G, Nierras CR, Todd JA, Rich SS, Nerup J.

Diabetes. 2010 Jul;59(7):1561-71. doi: 10.2337/db10-0076. Review. No abstract available.

48.

HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families.

Varney MD, Valdes AM, Carlson JA, Noble JA, Tait BD, Bonella P, Lavant E, Fear AL, Louey A, Moonsamy P, Mychaleckyj JC, Erlich H; Type 1 Diabetes Genetics Consortium.

Diabetes. 2010 Aug;59(8):2055-62. doi: 10.2337/db09-0680. Epub 2010 Apr 27. Erratum in: Diabetes. 2011 Dec;60(12):3308-10.

49.

Nomenclature for factors of the HLA system, 2010.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Fernández-Viña M, Geraghty DE, Holdsworth R, Hurley CK, Lau M, Lee KW, Mach B, Maiers M, Mayr WR, Müller CR, Parham P, Petersdorf EW, Sasazuki T, Strominger JL, Svejgaard A, Terasaki PI, Tiercy JM, Trowsdale J.

Tissue Antigens. 2010 Apr;75(4):291-455. doi: 10.1111/j.1399-0039.2010.01466.x. Review. No abstract available.

50.

Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort.

Morgan AW, Robinson JI, Conaghan PG, Martin SG, Hensor EM, Morgan MD, Steiner L, Erlich HA, Gooi HC, Barton A, Worthington J, Emery P; UKRAG Consortium; YEAR Consortium.

Arthritis Res Ther. 2010;12(2):R57. doi: 10.1186/ar2969. Epub 2010 Mar 30.

Supplemental Content

Loading ...
Support Center